¿Cuáles son los beneficios de la rehabilitación cardiopulmonar en la capacidad física y la calidad de vida de los pacientes con hipertensión pulmonar asociada a enfermedades del tejido conectivo?
DOI:
https://doi.org/10.28957/rcmfr.v30n5Palabras clave:
Rehabilitación, hipertensión pulmonar grado I, enfermedades del tejido conectivo, ejercicio, calidad de vidaResumen
La hipertensión arterial pulmonar es una condición que produce discapacidad con alteración en la funcionalidad y la calidad de vida de las personas que la padecen. En la hipertensión pulmonar grupo I se encuentran incluidas las personas con enfermedades del tejido conectivo quienes, por su condición de base, presentan mayor morbimortalidad, razón por la cual se describe el beneficio de terapias no farmacológicas como la rehabilitación cardiopulmonar con ejercicio aeróbico y de resistencia, como manejo coadyuvante a las terapias farmacológicas descritas en la mejoría de la capacidad física y la calidad de vida.
Referencias bibliográficas
Babu AS, Morris NR, Arena R, Myers J. Exercise-based evaluations and interventions for pulmonary hypertension with connective tissue disorders. Expert Rev Respir Med. 2018;12(7):615-622. Disponible en: http://doi.org/10.1080/17476348.2018.1481393
Sundaram SM, Chung L. An update on systemic sclerosis-associated pulmonar y arterial hypertension: A review of the current literature. Curr Rheumatol Rep. 2018; 20:10. Disponible en: https://doi.org/10.1007/s11926-018-0709-5
Zhao J, Wang Q, Liu Y, Tian Z, Guo X, Wang H, et al. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: a cohort study in China. Int J Cardiol. 2017;236:432-437. Disponible en: https://doi.org/10.1016/j.ijcard.2017.01.097
Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med. 2009;179(2):151. Disponible en: https://doi.org/10.1164/rccm.200806-953oc
Morris NR, Kermeen F, Holland A. Exercise?based rehabilitation programmes for pulmonary hypertension. Cochrane Database Syst. Rev. 2017;(1):CD011285. Disponible en: https://doi.org/10.1002/14651858.CD011285.pub2
Shoemaker MJ, Wilt JL, Dasgupta R, Oudiz RJ. Exercise training in patients with pulmonary arterial hypertension: a case report. Cardiopulm Phy Ther J. 2009;20(4):12-18. PMID: 20467524. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845256/
Vigil L, Güell MR, Morante F, López De Santamaría E, Sperti F, Guyatt G, et al. Validez y sensibilidad al cambio de la versión española autoadministrada del cuestionario de la enfermedad respiratoria crónica (CRQ-SAS). Arch Bronconeumol. 2011;47(7):343-349. Disponible en: http://doi.org/10.1016/j.arbres.2011.02.016
Aguirre-Camacho A, Stepanous J, Blanco-Donoso LM, Moreno-Jiménez B, Wilburn J, González- Saiz L, et al. Adaptation and Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for Use in Spain. Rev Esp Cardiol (Engl Ed). 2017;70(6):467-473. Disponible en: https://doi.org/10.1016/j.rec.2016.11.007
Fox BD, Kassirer M, Weiss I, Raviv Y, Peled N, Shitrit D, et al. Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension. J Card Fail. 2011;17(3):196-200. Disponible en: https://doi.org/10.1016/j.cardfail.2010.10.004
Grunig E, Ehlken N, Ghofrani A, Staehler G, Meyer FJ, Juenger J, et al. Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension. Respiration. 2011;81(5):394-401. Disponible en: https://doi.org/10.1159/000322475
Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM, et al. El cuestionario SF-36 español: una década de experiencias y nuevos desarrollos. Gac Sanit. 2005;19 (2):135-150. Disponible en: https://doi.org/10.1157/13074369
Grunig E, Maier F, Ehlken N, Fischer C, Lichtblau M, Blank N, et al. Exercise training in pulmonary arterial hypertension associated with connective tissue diseases. Arthritis Res Ther. 2012;14(3):R148. Disponible en: https://doi.org/10.1186/ar3883
Chan L, Chin LM, Kennedy M, Woolstenhulme JG, Nathan SD, Weinstein AA et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest. 2013;143(2):333-343. Disponible en: https://doi.org/10.1378/chest.12-0993
Ley S, Fink C, Risse F, Ehlken N, Fischer C, Ley-Zaporozhan J, et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. Eur Radiol. 2013;23(2):324–331. Disponible en: https://doi.org/10.1007/s00330-012-2606-z
Kabitz HJ, Bremer HC, Schwoerer A, Sonntag F, Walterspacher S, Walker DJ, et al. The combination of exercise and respirator y training improves respirator y muscle function in pulmonary hypertension. Lung. 2014;192(2):321– 28. Disponible en: https://doi.org/10.1007/s00408-013-9542-9
Babu AS, Arena R, Myers J, Padmakumar R, Maiya AG, Cahalin LP, et al. Exercise intolerance in pulmonary hypertension: Mechanism, evaluation and clinical implications. Expert Rev Respir Med. 2016;10(9):979-990. Disponible en: https://doi.org/10.1080/17476348.2016.1191353
Fowler RM, Gain KR, Gabbay E. Exercise intolerance in pulmonary arterial hypertension. Pulm Med. 2012;2012:359204 Disponible en: https://doi.org/10.1155/2012/359204
Kovacs G, Herve P, Barbera JA, Chaouat A, Chemla D, Condliffe R, et al. An official European Respirator y Society statement: pulmonar y haemodynamics during exercise. Eur Respir J. 2017;50(5):1700578. Disponible en: https://doi.org/10.1183/13993003.00578-2017
Provencher S, Hervé P, Sitbon O, Humbert M, Simonneau G, Chemla D. Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension. Eur Respir J. 2008;32(2):393-398. Disponible en: https://doi.org/10.1183/09031936.00009008
Mainguy V, Maltais F, Saey D, Gagnon P, Martel S, Simon M, et al. Effects of a rehabilitation program on skeletal muscle function in idiopathic pulmonary arterial hypertension. J Cardiopulm Rehabil Prev.2010;30(5):319-323. Disponible en: https://doi.org/10.1097/hcr.0b013e3181d6f962
Tolle J, Waxman A, Systrom D. Impaired systemic oxygen extraction at maximum exercise in pulmonary hypertension. Med Sci Sports Exerc. 2008;40(1):3-8. Disponible en: https://doi.org/10.1249/mss.0b013e318159d1b8
Wang S, Aurora AB, Johnson BA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15(2):261-271. Disponible en: https://doi.org/10.1016/j.devcel.2008.07.002
Suzuki A, Kondoh Y, Fischer A. Recent advances in connective tissue disease related interstitial lung disease. Expert Rev Respir Med. 2017;11(7):591-603. Disponible en: https://doi.org/10.1080/17476348.2017.1335600
Tedford RJ, Mudd JO, Girgis RE, Mathai SC, Zaiman AL, Housten-Harris T, et al. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circ Heart Fail. 2013;6(5):953-963. Disponible en: https://doi.org/10.1161/circheartfailure.112.000008
Rosato E, Romaniello A, Magrí D, Bonini M, Sardo L, Gigante A, et al. Exercise tolerance in systemic sclerosis patients without pulmonary impairment: correlation with clinical variables. Clin Exp Rheumatol. 2014;32(6-Suppl. 86):S103-S108. Disponible en: https:// www.clinexprheumatol.org/abstract.asp?a=7930
Van der Net J, Wissink B, van Royen A, Helders PJ, Takken T. Aerobic capacity and muscle strength in juvenile-onset mixed connective tissue disease (MCTD). Scand J Rheumatol. 2010;39(5):387-392. Disponible en: https://doi.org/10.3109/03009741003742714h
Frech T, Walker AE, Barrett-O’Keefe Z, Hopkins PN, Richardson RS, Wray DW, et al. Systemic sclerosis induces pronounced peripheral vascular dysfunction characterized by blunted peripheral vasoreactivity and endothelial dysfunction. Clin Rheumatol. 2015;34(5):905-913. Disponible https://doi.org/10.1007/s10067-014-2834-5
Berry NC, Manyoo A, Oldham WM, et al. Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice. Pulm Circ. 2015;5(4):610-618. Disponible en: https://doi.org/10.1086/683815
Babu AS, Myers J, Arena R, Maiya AG, Padmakumar R. Evaluating exercise capacity in patients with pulmonary arterial hypertension. Expert Rev Cardiovasc Ther.2013;11(6):729- 737. Disponible en: https://doi.org/10.1586/erc.13.33
Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur J.2014;44(6):1428-1446. Disponible en: http://doi.org/10.1183/09031936.00150314
Mathai SC, Puhan MA, Lam D, Wise RA. The minimal important difference in the 6- minute walk test for patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186(5):428-433. Disponible en: https://doi.org/10.1164/rccm.201203-0480oc
Rizzi M, Sarzi-Puttini P, Airoldi A, Antivalle M, Battellino M, Atzeni F. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease. Clin Exp Rheumatol. 2015;33(4 Suppl. 91):S142-S147. PMID: 26339893. Disponible en: https://www.clinexprheumatol.org/abstract.asp?a=9479
Cómo citar
Descargas
Descargas
Publicado
Número
Sección
Estadísticas de artículo | |
---|---|
Vistas de resúmenes | |
Vistas de PDF | |
Descargas de PDF | |
Vistas de HTML | |
Otras vistas |